Cost-effectiveness analysis of neonatal hearing screening program in china: should universal screening be prioritized?

Table 2 Parameter values and plausible ranges for cost estimates per case used in the baseline and sensitivity analysis (Int $)

Items	Hearing screening method	Baseline	Ranges for sensitivity analysis
			Minimum	Maximum
Screening
Program costs
Capital costs	OAE	240,813,700	170,712,610	307,291,540
	OAE+AABR	429,951,870	322,027,570	559,461,040
Recurrent costs	OAE	150	100	200
	OAE+AABR	230	130	360
Patient costs		30	10	50
Diagnosis
Program costs
Capital costs		15,950,600	11,014,773	21,467,600
Recurrent costs		240	130	360
Patient costs		170	90	310
Intervention
Program costs
Capital costs		13,829,240	12,430,260	15,554,540
Recurrent costs		290	200	440
Patient costs		22,690	18,860	29,140

Abbreviation: Otoacoustic emission (OAE); Automated auditory brainstem response (AABR)

ISSN: 1472-6963